Methylphenidate
Methylphenidate is an active ingredient in 20 FDA-listed drug products sold under 6 names.
Drugs containing Methylphenidate
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 70165-200 | Cotempla XR-ODT Tablet, Orally Disintegrating | 17.3 mg/1 | Neos Therapeutics Brands, LLC |
| 70165-300 | Cotempla XR-ODT Tablet, Orally Disintegrating | 25.9 mg/1 | Neos Therapeutics Brands, LLC |
| 70165-100 | Cotempla XR-ODT Tablet, Orally Disintegrating | 8.6 mg/1 | Neos Therapeutics Brands, LLC |
| 68968-5553 | Daytrana Patch | 15 mg/9h | Noven Therapeutics, LLC |
| 68968-5554 | Daytrana Patch | 20 mg/9h | Noven Therapeutics, LLC |
| 68968-5555 | Daytrana Patch | 30 mg/9h | Noven Therapeutics, LLC |
| 68968-5552 | Daytrana Patch | 10 mg/9h | Noven Therapeutics, LLC |
| 0378-8261 | Methylphenidate Patch | 1.6 mg/h | Mylan Pharmaceuticals Inc. |
| 0378-8262 | Methylphenidate Patch | 2.2 mg/h | Mylan Pharmaceuticals Inc. |
| 0378-8260 | Methylphenidate Patch | 1.1 mg/h | Mylan Pharmaceuticals Inc. |
| 0378-8263 | Methylphenidate Patch | 3.3 mg/h | Mylan Pharmaceuticals Inc. |
| 62542-250 | Methylphenidate Extended-Release Tablet, Orally Disintegrating | 17.3 mg/1 | Neos Therapeutics, LP |
| 62542-100 | Methylphenidate Extended-Release Tablet, Orally Disintegrating | 8.6 mg/1 | Neos Therapeutics, LP |
| 62542-350 | Methylphenidate Extended-Release Tablet, Orally Disintegrating | 25.9 mg/1 | Neos Therapeutics, LP |
| 43602-178 | Methylphenidate Hydrochloride Solution | 10 mg/5mL | Ascent Pharmaceuticals, Inc. |
| 43602-177 | Methylphenidate Hydrochloride Solution | 5 mg/5mL | Ascent Pharmaceuticals, Inc. |
| 0574-2420 | Methylphenidate Transdermal System Patch | 55 mg/mg | PADAGIS US LLC |
| 0574-2415 | Methylphenidate Transdermal System Patch | 41.3 mg/mg | PADAGIS US LLC |
| 0574-2410 | Methylphenidate Transdermal System Patch | 27.5 mg/mg | PADAGIS US LLC |
| 0574-2430 | Methylphenidate Transdermal System Patch | 82.5 mg/mg | PADAGIS US LLC |